An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  1985-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00496366PMID 4033804
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A procedure for the isolation of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from the same tissue sample using a single column of strongly acidic cation exchange resin.

  2009cited by this paper
• Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats

  2005cited by this paper
• Dopamine receptor agonists: Mechanisms underlying autoreceptor selectivity II. Theoretical considerations

  2005cited by this paper
• Differential effects of the enantiomers of 3-PPP on dopamine D1-receptors of isolated rabbit retina

  2005cited by this paper
• Dopamine receptor agonists: Intrinsic activity vs. state of receptor

  2005cited by this paper
• In vitro effect of the racemic mixture and the (−)enantiomer of N-n-propyl-3-(3-hydroxyphenyl)-piperidine (3-PPP) on postsynaptic dopamine receptors and on a presynaptic dopamine autoreceptor

  2005cited by this paper
• Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity

  2005cited by this paper
• Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP

  2004influential reference
• The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat

  2004cited by this paper
• Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers

  2004cited by this paper
• 3-PPP Enantiomers and Brain Sigma Opiate Sites: Discrepancies between in vitro and in vivo Observations

  1986cited by this paper
• Electrophysiological effects of the enantiomers of 3-PPP on neurons in the locus coeruleus of the rat.

  1986cited by this paper
• The effects of SCH 23390, YM 09151-2, (+)- and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro.

  1984cited by this paper
• THE EFFECTS OF NOVEL DOPAMINERGIC AGONISTS ON THE NIGROSTRIATAL DOPAMINE SYSTEM

  1984cited by this paper
• (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.

  1984cited by this paper
• Differential effects of the stereoisomers of 3PPP in dopaminergic and cholinergic neurotransmission in superfused slices of the corpus striatum

  1984cited by this paper
• Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.

  1984cited by this paper
• A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists.

  1984cited by this paper
• Opposite responses in the striato-nigral substance P system to D1 and D2 receptor activation.

  1984cited by this paper
• Electrophysiological studies on EMD 23 448, an indolyl-3-butylamine, in the rat: a putative selective dopamine autoreceptor agonist.

  1983cited by this paper
• Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.

  1983cited by this paper
• Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers.

  1983cited by this paper
• Chloral hydrate anesthesia alters the responsiveness of dorsal raphe neurons to psychoactive drugs.

  1983cited by this paper
• On the mode of action of 3-(3-hydroxyphenyl)-N-n-propylpiperidine, 3-PPP, and its enantiomers. With particular reference to dopaminergic mechanisms in the central nervous system.

  1983influential reference
• Low-dose apomorphine and bromocriptine in neuroleptic-induced movement disorders.

  1983cited by this paper
• Effects of putative dopamine autoreceptor agonists in pharmacological models related to dopaminergic and neuroleptic activity.

  1982cited by this paper
• Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.

  1981cited by this paper
• 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors.

  1981cited by this paper
• Dopaminergic neurons in the rat ventral tegmental area. I. Identification and characterization

  1981cited by this paper
• Nigral dopamine neurons: intracellular recording and identification with L-dopa injection and histofluorescence.

  1980cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Action of systemic apomorphine on dopamine cell firing after neostriatal kainic acid lesion.

  1980cited by this paper
• Dopamine auto- and postsynaptic receptors: electrophysiological evidence for differential sensitivity to dopamine agonists.

  1979influential reference
• Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons.

  1979influential reference
• The effects of acute and chronic haloperidol treatment on spontaneously firing neurons in the caudate nucleus of the rat.

  1979cited by this paper
• Behavioral Actions of Neuroleptics

  1978cited by this paper
• d-Amphetamine-induced depression of central dopamine neurons: Evidence for mediation by both autoreceptors and a striato-nigral feedback pathway

  1978cited by this paper
• Schizophrenic symptoms improve with apomorphine.

  1978cited by this paper
• MECHANISM OF ACTION OF NEUROLEPTIC DRUGS

  1978cited by this paper
• Effect of apomorphine on schizophrenic symptoms

  1977cited by this paper
• Sedative, hypnotic, and antipsychotic effects of low doses of apomorphine in man.

  1977cited by this paper
• Dopamine “Autoreceptors”: Pharmacological characterization by microiontophoretic single cell recording studies

  1977cited by this paper
• Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

  1976cited by this paper
• Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity.

  1975cited by this paper
• To spritz or not to spritz: the doubtful value of aimless iontophoresis.

  1974cited by this paper
• Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons.

  1974cited by this paper
• Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input.

  1974cited by this paper
• The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay

  1973cited by this paper
• Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity.

  1973cited by this paper
• A simple, direct and rapid method for filling microelectrodes

  1968cited by this paper
• Micromethods in neuropharmacology: an approach to the study of anesthetics.

  1967cited by this paper
• The Rat Drain. A Stereotaxic Atlas

  1964cited by this paper

• Network Experimental Approaches

  2014cites this paper
• Design and synthesis of polycyclic amine derivatives for sigma receptor activity

  2013cites this paper
• The role of sigma receptors in depression.

  2005cites this paper
• Effects on locomotor activity after local application of (+)-UH232 in discrete areas of the rat brain

  2005cites this paper
• Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivity

  2005cites this paper
• Capsaicin-sensitive vasodilatatory mechanisms in the rat substantia nigra and striatum

  2005cites this paper
• On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats

  2004cites this paper
• Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.

  2002cites this paper
• Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity

  2002cites this paper
• The delayed effects of DTG and MK-801 on latent inhibition in a conditioned taste-aversion paradigm.

  2000cites this paper
• The role of striatal dopaminergic mechanisms in rotational behavior induced by phencyclidine and phencyclidine-like drugs

  1998cites this paper
• The pharmacology of the novel and selective sigma ligand, PD 144418.

  1997cites this paper
• Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists.

  1996cites this paper
• Inhibition by a putative antipsychotic quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental area.

  1996cites this paper
• Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors

  1996cites this paper
• Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders.

  1996cites this paper
• CI-1007, a dopamine partial agonist and potential antipsychotic agent. II. Neurophysiological and behavioral effects.

  1995cites this paper
• Neuroprotective sigma ligands interfere with the glutamate‐activated NOS pathway in hippocampal cell culture

  1995cites this paper
• Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole.

  1995cites this paper
• Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.

  1995cites this paper
• Differential effects of 3-PPP enantiomers on extracellular dopamine concentration in the caudate-putamen and nucleus accumbens of rats

  1994cites this paper
• Effects of sigma ligands on rat cerebellar Purkinje neuron firing: an iontophoretic study.

  1994cites this paper
• Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.

  1994cites this paper
• Electrophysiological effects of putative autoreceptor-selective dopamine agonists on A10 dopamine neurons.

  1993cites this paper
• Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.

  1993cites this paper
• Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.

  1993cites this paper
• Pharmacological profile of the dopamine partial agonist, (+/-)-PD 128483 and its enantiomers.

  1993cites this paper
• Topographic heterogeneity of substantia nigra neurons: diversity in intrinsic membrane properties and synaptic inputs.

  1993cites this paper
• Iontophoretic effects of sigma ligands on rubral neurons in the rat.

  1992cites this paper
• Biphasic dose-dependent effects of dopamine and involvement of dopamine autoreceptors on intra-ocular pressure in the rabbit.

  1992cites this paper
• Effects of the preferential dopamine autoreceptor antagonist (+)-AJ76 in the intracranial self-stimulation paradigm.

  1992cites this paper
• Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency

  1992cites this paper
• Immunohistochemical markers in rat brain: colocalization of calretinin and calbindin-D28k with tyrosine hydroxylase.

  1992cites this paper
• Involvement of haloperidol-sensitive sigma-sites in antitussive effects.

  1992cites this paper
• Relationship between brain levels of 3-(3-hydroxyphenyl)-N-n-propylpiperidine HCl enantiomers and effects on locomotor activity in rats.

  1992cites this paper
• Acute effects of Sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons

  1992cites this paper
• In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.

  1992cites this paper
• Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors

  1991cites this paper
• Dopamine D2 mechanisms in canine narcolepsy

  1991cites this paper
• Behavioural profile of partial D2 dopamine receptor agonists

  1991cites this paper
• Sigma-receptors: implication for the control of neuronal activity of nigral dopamine-containing neurons.

  1991cites this paper
• Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons.

  1990cites this paper
• Sigma receptors: biology and function.

  1990cites this paper
• Statistical analysis of dose‐response curves in extracellular electrophysiological studies of single neurons

  1990cites this paper
• D-2 dopamine autoreceptor selective drugs: do they really exist?

  1990cites this paper
• Dopamine neuron ontogeny: Electrophysiological Studies

  1990cites this paper
• Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration

  1989cites this paper
• Electrophysiological and pharmacological evidence for the existence of distinct subpopulations of nigrostriatal dopaminergic neuron in the rat.

  1988cites this paper
• SKF 38393 alters the rate‐dependent D2‐mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons

  1988cites this paper
• Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology.

  1988cites this paper
• Effects of intraperitoneal administration of apomorphine and the isomers of 3-(1-propyl-3-piperidinyl)phenol on the firing activity of substantia nigra dopamine neurons: comparison of agonist efficacies and development of acute tolerance.

  1988cites this paper
• NSD 1034: An amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors

  1988cites this paper
• Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons.

  1988cites this paper
• Morphology and electrophysiology of ventral mesencephalon nerve cell cultures.

  1988cites this paper
• B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence.

  1988cites this paper
• Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat

  1988cites this paper
• Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.

  1988cites this paper
• Update on Dopamine Agonists in Parkinson's Disease: “Beyond Bromocriptine”

  1987cites this paper
• Autoreceptors in the central nervous system

  1987cites this paper
• The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems

  1987cites this paper
• D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.

  1987cites this paper
• Electrophysiological effects of the enantiomers of 3-PPP on neurons in the locus coeruleus of the rat.

  1986cites this paper
• The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.

  1986cites this paper
• GBR 13098, a selective dopamine uptake inhibitor; behavioural, biochemical and electrophysiological studies

  1986cites this paper
• Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.

  1986cites this paper
• Central dopaminergic properties of HW-165 and its enantiomers; Trans-octahydrobenzo(f)quinoline congeners of 3-PPP

  1986cites this paper